NCT05700370View on ClinicalTrials.gov

MyProstateScore Equivalency With and Without DRE

NAUnknownINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

MyProstateScore

MyProstateScore is a urine-based biomarker test used to predict the risk of clinically significant prostate cancer

Trial Locations (1)

85044

Arizona State Urological Institute, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LynxDx

INDUSTRY